跳转至内容
Merck

94687

Supelco

依维莫司

analytical standard

别名:

42-O-(2-羟乙基)雷帕霉素

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C53H83NO14
分子量:
958.22
MDL號碼:
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

analytical standard

品質等級

化驗

≥75.0% (qNMR)

儲存期限

limited shelf life, expiry date on the label

應用

clinical testing

格式

neat

儲存溫度

−20°C

SMILES 字串

O=C(C([C@@]1(O)[C@H](C)CC[C@](C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C2=O)([H])O1)=O)N3[C@H](C(O[C@@]([C@@H](C[C@@]4([H])C[C@@H](OC)[C@H](OCCO)CC4)C)([H])CC([C@H](C)/C=C(C)/[C@@H](O)[C@H]2OC)=O)=O)CCCC3

InChI

1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1

InChI 密鑰

HKVAMNSJSFKALM-GKUWKFKPSA-N

基因資訊

human ... FKBP1A(2280)

正在寻找类似产品? 访问 产品对比指南

一般說明

Everolimus (RAD001), a derivative of rapamycin, is commonly used as a drug for the inhibition of the mTOR pathway, affecting tumor cell division and angiogenesis.

應用

Everolimus may be used as a standard in the following clinical studies:
  • Investigation of its glucose-dependent growth-inhibitory property in breast cancer cell lines.
  • Evaluate its possible antiproliferative effects in human bronchial carcinoids in primary culture.

象形圖

Health hazardEnvironment

訊號詞

Warning

危險分類

Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 2 - Repr. 2 - STOT RE 2

標靶器官

Kidney,Testes

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable


Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids
Zatelli CM, et al.
Endocrine-Related Cancer, 17(3), 719-729 (2010)
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells
Nishi T, et al.
Cancer letters, 331(2), 220-229 (2013)
Cardiac Electrophysiology: From Cell to Bedside, 17(1), 232-232 (2016)
Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells
Ariaans G, et al.
BMC Cancer, 17(1), 232-232 (2017)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门